Cargando…
Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis
Metformin is a biguanide widely prescribed to treat Type II diabetes that has gained interest as an antineoplastic agent. Recent work suggests that metformin directly antagonizes cancer cell growth through its actions on complex I of the mitochondrial electron transport chain (ETC). However, the mec...
Autores principales: | Griss, Takla, Vincent, Emma E., Egnatchik, Robert, Chen, Jocelyn, Ma, Eric H., Faubert, Brandon, Viollet, Benoit, DeBerardinis, Ralph J., Jones, Russell G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666657/ https://www.ncbi.nlm.nih.gov/pubmed/26625127 http://dx.doi.org/10.1371/journal.pbio.1002309 |
Ejemplares similares
-
Differential effects of AMPK agonists on cell growth and metabolism
por: Vincent, Emma E., et al.
Publicado: (2014) -
Metabolic plasticity maintains proliferation in pyruvate dehydrogenase deficient cells
por: Rajagopalan, Kartik N., et al.
Publicado: (2015) -
Detection of glucose-derived d- and l-lactate in cancer cells by the use of a chiral NMR shift reagent
por: Suh, Eul Hyun, et al.
Publicado: (2021) -
Metabolic heterogeneity in cancer
por: DeBerardinis, Ralph J
Publicado: (2014) -
Q&A: Targeting metabolism to diagnose and treat cancer
por: DeBerardinis, Ralph J
Publicado: (2014)